Patent classifications
A61K35/612
Omega-3 fatty acid nutriceutical composition and optimization method
A novel omega-3 fatty acid/lipid based nutraceutical composition and a method of optimizing said omega-3 fatty acid/lipid based nutraceutical composition. The nutraceutical composition and method is based on the insight that different forms of high omega-3 fatty acid lipids (e.g. triglyceride form, ethyl ester form, free fatty acid form, phospholipid form) have different molecular modes and levels of action. Specifically the phospholipid form is likely more effective at promoting membrane fluidity and permeability, while the free fatty acid form is likely more effective at regulating cell receptors, such as the PPARa receptors, that are responsible for various metabolic effects including lipid metabolism. The desirability of producing omega-3 compositions that may act synergistically and thus more robustly to improve health and to some extent mimic markers of life extension such as shown by caloric restriction, along with specific optimization methods, markers, and compositions are taught.
Probiotic Confection and Lipid Compositions
The present application relates to probiotic confection-based compositions comprising lactic acid-producing bacteria and oil-based compositions comprising the same.
Probiotic Confection and Lipid Compositions
The present application relates to probiotic confection-based compositions comprising lactic acid-producing bacteria and oil-based compositions comprising the same.
Cosmetic compositions
Disclosed are compositions and methods that can be used to improve the skin's visual appearance. In certain aspects, the compositions disclosed herein can include, for example, a combination of ingredients to exfoliate, reduce or eliminate irritation from exfoliation, renew the skin, increase skin radiance, sooth the skin, or increase skin smoothness. This combination of ingredients can be included in a wide-range of product formulations (e.g., serums, eye creams, toners, gels, masks, peels, etc.).
Marine material derived from early developmental stages of barnacles
The present invention relates to a nutritional product comprising a biological material derived from eggs and/or nauplii of stage I of a barnacle and its uses. The invention, especially discloses a feed for early live stages of aquatic animals such as fish or crustaceans comprising isolated eggs and/or nauplii of stage I of a barnacle or a material derived thereof. Methods for harvesting, isolating and preservation of the biological barnacle material are also disclosed.
Marine material derived from early developmental stages of barnacles
The present invention relates to a nutritional product comprising a biological material derived from eggs and/or nauplii of stage I of a barnacle and its uses. The invention, especially discloses a feed for early live stages of aquatic animals such as fish or crustaceans comprising isolated eggs and/or nauplii of stage I of a barnacle or a material derived thereof. Methods for harvesting, isolating and preservation of the biological barnacle material are also disclosed.
PREPARATION AND USE OF AN EXTRACT OF ARTEMIA SALINA TO TREAT THE OCULAR SURFACE
The present invention relates to the preparation of an extract of the crustacean Artemia salina and to the use thereof to treat diseases of the ocular surface. The invention describes the application of the extract mainly by means of soaps, eyedrops, eye solutions, eye washes, aerosols, in the presence of unguents, creams, gels or contact lenses, inter alia. The application of the Artemia salina extract is efficient for treating pathologies consistent with ocular dryness (dry eye) and the manifestations thereof such as the appearance of injuries or ulcers on the ocular surface or infections caused by microorganisms and associated with dry eye, also on of the ocular surface.
Solid beverage for conditioning yin deficiency constitution and method for producing the same
Provided is a solid beverage for conditioning yin deficiency constitution. The solid beverage includes the following components in parts by weight: 30-55 parts of smoked plum, 29-51 parts of lilium brownii, 27-50 parts of polygonatum odoratum, 30-52 parts of mulberry leaves, 27-48 parts of mulberries, 26-58 parts of fresh reed rhizome, 67-94 parts of oysters, 3-15 parts of amomum villosum, 27-50 parts of dextrin, 16-43 parts of maltodextrin, 38-70 parts of soluble starch and 0.15-0.35 parts of aspartame. The solid beverage is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, a long-term consumption of the solid beverage has certain effects on the improvement of yin deficiency constitution, and the production process thereof is suitable for industrial mass production.
Solid beverage for conditioning yin deficiency constitution and method for producing the same
Provided is a solid beverage for conditioning yin deficiency constitution. The solid beverage includes the following components in parts by weight: 30-55 parts of smoked plum, 29-51 parts of lilium brownii, 27-50 parts of polygonatum odoratum, 30-52 parts of mulberry leaves, 27-48 parts of mulberries, 26-58 parts of fresh reed rhizome, 67-94 parts of oysters, 3-15 parts of amomum villosum, 27-50 parts of dextrin, 16-43 parts of maltodextrin, 38-70 parts of soluble starch and 0.15-0.35 parts of aspartame. The solid beverage is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, a long-term consumption of the solid beverage has certain effects on the improvement of yin deficiency constitution, and the production process thereof is suitable for industrial mass production.
PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF THERAPEUTIC COMPOUNDS
The present invention relates to compositions comprising phospholipids for delivery of bioactive compounds such as ethyl esters, fish oil concentrates, cannabinoids, and curcumin under conditions such the bioavailability of the bioactive compounds is enhanced.